The Effect of Asymmetrical vs. Symmetrical High Flow Nasal Cannula on the Work of Breathing
Launched by LARISSA UNIVERSITY HOSPITAL · Jul 3, 2025
Trial Information
Current as of August 31, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways of delivering high flow oxygen through the nose to people who have recovered from lung diseases and are currently stable. The goal is to see if an “asymmetrical” nasal high flow device helps reduce the effort it takes to breathe compared to a “symmetrical” device. Simply put, researchers want to find out which device makes breathing easier for these patients.
People aged 18 and older who do not have any signs of ongoing breathing problems and have good oxygen levels may be eligible to join. During the study, participants will try both types of nasal oxygen devices for about 15 minutes each, in a random order. While they use these devices, doctors will monitor their breathing effort and lung function using safe, non-invasive tests. This study is important because it may help improve breathing support for people recovering from lung conditions, making it easier and more comfortable for them to breathe.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. age ≥18 years old
- • 2. absence of symptoms and signs of respiratory failure (SpO2\>95% at FiΟ2 0.21)
- Exclusion Criteria:
- • 1. pregnancy
- • 2. SpO2\<94% at FiΟ2 0.21
- • 3. neuromuscular disease
- • 4. contraindications to esophageal pressure monitoring (e.g., uncontrolled coagulopathy, esophageal disease, nasal trauma, allergy to local lidocaine)
About Larissa University Hospital
Larissa University Hospital is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and education. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge scientific inquiry with patient-centered care, fostering a collaborative environment for researchers, healthcare professionals, and participants. With a commitment to improving medical outcomes, Larissa University Hospital emphasizes ethical practices, rigorous methodologies, and interdisciplinary approaches in its clinical trials, contributing significantly to the development of new therapies and interventions across various medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Larissa, , Greece
Patients applied
Trial Officials
Demosthenes Makris
Study Chair
Professor of Intensive Care Unit, University Hospital of Larissa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported